Literature DB >> 10348349

Induction of apoptosis and G2/M cell cycle arrest by DCC.

Y Q Chen1, J T Hsieh, F Yao, B Fang, R C Pong, S C Cipriano, F Krepulat.   

Abstract

The Deleted in Colorectal Cancer gene (DCC) encodes a cell surface receptor that belongs to the Ig superfamily. Inactivation of the DCC gene has been implicated in human tumor progression. However, little is known about the biological function of the DCC protein. In the present study, we demonstrated that expression of DCC activated caspase-3 and programmed cell death, or induced G2/M cell cycle arrest in tumor cells. In some cell lines, apoptosis was evident within 24 h of DCC expression. Timing of the appearance of apoptotic cells coincided with that of the cleavage of poly (ADP-ribose) polymerase, a substrate of caspase-3. Expression of the apoptosis inhibitory gene Bcl-2 was not able to abrogate the DCC-induced apoptosis. In the G2/M cycle arrest cells, cdk1 activity was inhibited. Our results suggest that the DCC protein may transduce signals resulting in activation of caspases or inhibition of Cdk1. These data provide a possible mechanism by which DCC suppresses tumorigenesis.

Entities:  

Mesh:

Year:  1999        PMID: 10348349     DOI: 10.1038/sj.onc.1202629

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

Review 1.  Dependence receptors: between life and death.

Authors:  P Mehlen; C Thibert
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 2.  Calcium, a Cell Cycle Commander, Drives Colon Cancer Cell Diffpoptosis.

Authors:  Ahmed A Abd-Rabou
Journal:  Indian J Clin Biochem       Date:  2016-03-30

Review 3.  The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma.

Authors:  Elena Tassi; Anton Wellstein
Journal:  Semin Oncol       Date:  2006-12       Impact factor: 4.929

4.  The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation.

Authors:  C Forcet; X Ye; L Granger; V Corset; H Shin; D E Bredesen; P Mehlen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

5.  Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function.

Authors:  Chen Wang; Xiaowen Li; Kaida Mu; Ling Li; Shihong Wang; Yunxia Zhu; Mingliang Zhang; Jiyoon Ryu; Zhifang Xie; Dongyun Shi; Weiping J Zhang; Lily Q Dong; Weiping Jia
Journal:  Diabetologia       Date:  2013-06-22       Impact factor: 10.122

6.  Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -.

Authors:  Elena Tassi; Anton Wellstein
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

Review 7.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

8.  Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival.

Authors:  Bhama Ramkhelawon; Yuan Yang; Janine M van Gils; Bernd Hewing; Katey J Rayner; Sajesh Parathath; Liang Guo; Scott Oldebeken; Jessica L Feig; Edward A Fisher; Kathryn J Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-18       Impact factor: 8.311

9.  Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.

Authors:  S M Sureban; S Ramalingam; G Natarajan; R May; D Subramaniam; K S Bishnupuri; A R Morrison; B K Dieckgraefe; D J Brackett; R G Postier; C W Houchen; S Anant
Journal:  Oncogene       Date:  2008-04-21       Impact factor: 9.867

10.  Netrin-1 is a survival factor during commissural neuron navigation.

Authors:  Céline Furne; Nicolas Rama; Véronique Corset; Alain Chédotal; Patrick Mehlen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.